Tandem wins approval for insulin pump in Canada

Tandem Diabetes Care (NSDQ:TNDM) won a medical device license from Health Canada last week for its t:slim X2 insulin pump.
The device integrates directly with Dexcom‘s (NSDQ:DXCM) G5 continuous glucose monitor and is the only system of its kind approved in Canada, according to the San Diego, Calif.-based company.
Get the full story at our sister site, Drug Delivery Business News.
The post Tandem wins approval for insulin pump in Canada appeared first on MassDevice.

Source: Mass Device - October 15, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Featured Pharmaceuticals Regulatory/Compliance Wall Street Beat Dexcom tandemdiabetes Source Type: news